Transferrin promotes fatty acid oxidation and liver tumor growth through PHD2-mediated PPARα hydroxylation in an iron-dependent manner
Proceedings of the National Academy of Sciences · 04.02.2025 · 122 (5)
DOI: 10.1073/pnas.2412473122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 31.01.2025. Verfasst von Xu Qian und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310022, China. Hauptthemen laut MEDLINE: PPAR alpha, Liver Neoplasms, Hypoxia-Inducible Factor-Proline Dioxygenases, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China (MOST), MOST | National Natural Science Foundation of China (NSFC), MOST | NSFC | NSFC-Zhejiang Joint Fund | Natural Science Foundation of Zhejiang Province (ZJNSF).
Abstract (Originalsprache)
Tumor cells reshape iron and lipid metabolism for their rapid proliferation. However, how tumor cells coordinate the interplay between tumor cell–specific iron homeostasis and lipid metabolism reprogramming to counteract energy shortages remains unclear. Here, we demonstrated that glucose deprivation in hepatocellular carcinoma (HCC) cells induced AMPK-dependent Transferrin S685 phosphorylation, which exposed Transferrin nuclear localization signal (NLS) for binding to importin α7 and subsequent nuclear translocation. Nucleus-translocated Transferrin interacts with PPARα and enhance its protein stability to increase fatty acid oxidation (FAO) upon glucose deprivation. Mechanistically, PPARα-associated Transferrin upregulates iron-dependent PHD2-mediated PPARα P87 hydroxylation and subsequently disrupts the binding of MDM2 to PPARα, therefore inhibiting MDM2-mediated PPARα ubiquitination and degradation. Reconstitution of Transferrin S685A and NLS mutation or knock-in expression of PPARα P87A inhibited PPARα-mediated FAO upon energy stress, enhanced HCC cell apoptosis, and impeded liver tumor growth in mice. Importantly, combined treatment with Transferrin pS685 blocking peptide suppressing AMPK-Transferrin-PPARα axis could synergize with a well-established AMPK activator Metformin to inhibit tumor growth. Additionally, Transferrin pS685-mediated PPARα P87 hydroxylation is positively correlated with PPARα expression levels in human HCC specimens and poor patient prognosis. These findings revealed a mechanism by which Transferrin can sense energy stress to promote the hydroxylation and protein stability of PPARα through iron-dependent activation of PHD2 and underscore the moonlighting function of Transferrin in lipid catabolism and liver tumor development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou 310022, China.
- Zhejiang Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, and Institute of Translational Medicine, Zhejiang University Schoo…
- Institute of Fundamental and Transdisciplinary Research, Cancer Center, Zhejiang University, Hangzhou, Zhejiang 310029, China.
- Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
- Laboratory of Oral Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai 200125, China.
- National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, China.
ORCID-Profile: Yuan Ouyang, Yueru Hou, Peng Zhan, Daqian Xu
Förderung
- Ministry of Science and Technology of the People's Republic of China (MOST)
- MOST | National Natural Science Foundation of China (NSFC)
- MOST | NSFC | NSFC-Zhejiang Joint Fund | Natural Science Foundation of Zhejiang Province (ZJNSF)
- Shanghai Municipal Human Resources and Social Security Bureau
- MOST | NSFC | NSFC-Zhejiang Joint Fund | Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents
- Zhejiang University (ZJU)
Zitieren
APA
Qian, X., Zhou, Q., Ouyang, Y., Wu, X., Sun, X., Wang, S., Duan, Y., Hu, Z., Hou, Y., Wang, Z., Chen, X., Wang, K. L., Shen, Y., Dong, B., Lin, Y., Wen, T., Tian, Q., Guo, Z., Li, M., …, & Xu, D. (2025). Transferrin promotes fatty acid oxidation and liver tumor growth through PHD2-mediated PPARα hydroxylation in an iron-dependent manner. Proceedings of the National Academy of Sciences, 122(5). https://doi.org/10.1073/pnas.2412473122
Vancouver
Qian X, Zhou Q, Ouyang Y, Wu X, Sun X, Wang S, et al. Transferrin promotes fatty acid oxidation and liver tumor growth through PHD2-mediated PPARα hydroxylation in an iron-dependent manner. Proceedings of the National Academy of Sciences. 2025;122(5). doi:10.1073/pnas.2412473122
BibTeX
@article{Qian2025,
author = {Qian, Xu and Zhou, Qimin and Ouyang, Yuan and Wu, Xiaohong and Sun, Xue and Wang, Shuo and Duan, Yuran and Hu, Zhiqiang and Hou, Yueru and Wang, Zheng and Chen, Xiaohan and Wang, Katherine L and Shen, Yuli and Dong, Bofei and Lin, Yanni and Wen, Ting and Tian, Qi and Guo, Zhanpeng and Li, Min and Xiao, Liwei and Wu, Qingang and Meng, Ying and Liu, Guijun and Ying, Hangjie and Zhou, Yahui and Zhang, Wuchang and Duan, Shengzhong and Bai, Xueli and Liu, Tong and Zhan, Peng and Lu, Zhimin and Xu, Daqian},
title = {Transferrin promotes fatty acid oxidation and liver tumor growth through PHD2-mediated PPARα hydroxylation in an iron-dependent manner},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {5},
doi = {10.1073/pnas.2412473122}
}
EUVIMED